AXIOS June 5, 2023
Tina Reed

Cancer doctors and dozens of lawmakers in Congress are questioning whether the federal health department overreached when it blocked medical practices from mailing specialty drugs like oral cancer and blood clotting treatments directly to patients at the end of the COVID public health emergency.

Why it matters: At issue is the Biden administration’s interpretation of a federal anti-fraud law that bars doctors from steering Medicare and Medicaid patients to facilities and services in which they have a financial interest.

  • The Centers for Medicare and Medicaid Services waived sanctions during the pandemic but now considers the shipments a violation of the law that could get providers fined or even kicked out of Medicare and Medicaid.

Yes, but: Some providers...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: CMS, Congress / White House, Govt Agencies, Healthcare System, Patient / Consumer, Provider, Public Health / COVID
From doctor to patient: my Sjogren’s journey and a challenge to colleagues
Global Inequities In Access To Drugs Costs Millions Of Lives Each Year
Loneliness Linked to Increased Mortality Risk in Cancer Survivors
'That's a Society-Ending Pandemic': What We Heard This Week
Effectiveness of managing conditions with remote patient monitoring | Viewpoint

Share This Article